MedCity News September 28, 2025
Thyme Care’s Series D round included participation from CVS Health Ventures, Foresite Capital, Morgan Health and Humana. In total, it has raised $275 million.
Thyme Care, a value-based cancer care company, has secured $97 million in Series D funding to scale its platform to more patients, it announced on Thursday.
Nashville, Tennessee-based Thyme Care, founded in 2020, partners with health plans, employers and risk-bearing providers to support patients battling cancer. It offers care navigation services, technology and data insights and therapeutic interventions. The company helps patients understand their diagnosis, find a cancer doctor and receive clinical care between appointments. Patients also gain access to a team of providers, nurses and resource specialists. Its services are available to 8 million people...
Today's Sponsors
Today's Sponsor